Debate: Targeting the immune system with checkpoint inhibitors - Single drug therapy

preview_player
Показать описание
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Naiyer Rizvi argues in favor of single drug therapy for targeting the immune system with checkpoint inhibitors.

Earn CME credit for a related activity at the following location:

© 2016 Imedex, LLC.
  1. HMP Education
  2. Imedex
  3. CME
  4. Continuing Medical Education
  5. Education
  6. Accreditation
Рекомендации по теме
Debate: Targeting the 0:15:04

Debate: Targeting the immune system with checkpoint inhibitors - Single drug therapy

Debate: Targeting the 0:23:11

Debate: Targeting the immune system with checkpoint inhibitors - Combination therapy

State of the 0:59:47

State of the Science 2021 #7: Targeting the Immune System in Type 1 Diabetes

Targeting the immune 0:27:43

Targeting the immune system with checkpoint inhibitors

Targeting Cancer: Immune 0:06:05

Targeting Cancer: Immune Checkpoint Inhibitors - FINAL VERSION

Duration of checkpoint 0:09:54

Duration of checkpoint inhibitor therapy

Scientist reacts to 0:14:57

Scientist reacts to Mikhaila Peterson Oxford meat debate

Tumor-Related Immune Checkpoints 0:03:39

Tumor-Related Immune Checkpoints And The Development Of Targeted Cancer Immunotherapies

James P. Allison, 0:40:23

James P. Allison, Ph.D., on Targeting Immune Checkpoints in Cancer Therapy

Davide Vecchi and 0:20:37

Davide Vecchi and Giorgio Airoldi

Panel Debate: Is 0:18:06

Panel Debate: Is There a Role for Personalized Medicine in MDS?

Debates at COMy 0:01:14

Debates at COMy 2022: MRD, immune therapies, and more

Debate: Is there 0:09:12

Debate: Is there an optimal treatment for refractory colorectal cancer? - Immunotherapy

Immune checkpoint inhibitors 0:17:44

Immune checkpoint inhibitors in lymphoma

Debate: Can biomarkers 0:12:29

Debate: Can biomarkers beyond MSI direct immunotherapy in GI malignancies? - No

CTAF Meeting on 0:59:28

CTAF Meeting on Targeted Immune Modulators for Ulcerative Colitis- Voting Questions

Dr. Lee on 0:01:35

Dr. Lee on B-Cell Receptor Targeting in Relapsed/Refractory MCL

CRSF 07th Masterclass 0:25:59

CRSF 07th Masterclass Debate: Dr. Sudeep Das vs. Dr. Sandeep Ishi on Neoadjuvant vs. Adjuvant IO

Debate: Should immunotherapy 0:09:27

Debate: Should immunotherapy be used alone? - No, only in combination with chemotherapy

Targeting autophagy via 0:06:33

Targeting autophagy via TFEB activation - Ghada Alsaleh (Oxford)

Debate: Optimal salvage 0:07:20

Debate: Optimal salvage therapy for refractory colon cancer? - Immunotherapy

TKIs, Apoptotic Enhancers, 0:28:25

TKIs, Apoptotic Enhancers, and other Small Molecules in the Pipeline

The Great Debate: 0:51:35

The Great Debate: Sensitive versus Susceptible -- Amanda Mercurio, PharmD

Debate: MSI High 0:09:25

Debate: MSI High Colon Cancer - Immunotherapy

welcome to shbcf.ru